Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Multi-class segmentation of aortic branches and zones in computed tomography angiography: The AortaSeg24 challenge.

Medical image analysis·2026
Same author

Respiratory motion augmentation for personalized super-resolution (RMApSR) of 3D cine MR images in MRI-guided radiotherapy.

Medical image analysis·2026
Same author

Enhancing Cognitive Functions of Older Adults With Software Robot: Longitudinal Exploratory Field Study.

JMIR mHealth and uHealth·2026
Same author

Automated dose-gradient curve and dose-volume histogram analysis platform: development, validation, and clinical decision support with TG-119 datasets.

Frontiers in oncology·2026
Same author

Effects of apolipoprotein E ε4 on amyloid deposition and relative cerebral perfusion in cognitively normal individuals: a dual-phase 18F-florbetaben PET study.

Nuclear medicine communications·2026
Same author

A proof-of-concept automated method for accurate skin dosimetry: correcting overestimated surface dose measurements.

Physics in medicine and biology·2026

Video Experimental Relacionado

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

Desarrollo de Fármacos

So Yoon Park1,2, Ju Hyun Lee1, Whani Kim1

  • 1HAII Inc., Seoul, Korea, Republic of (South).

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 26, 2025
PubMed
Resumen
Este resumen es generado por máquina.

La combinación de tres tareas de habla (Lectura Guionizada, Preguntas y Respuestas Basadas en Imágenes, Narración Espontánea) detecta eficazmente el Deterioro Cognitivo Leve (DCL). Las características acústicas del habla espontánea son cruciales para la detección precisa del DCL.

Palabras clave:
biomarcadores de vozdeterioro cognitivo levedetección tempranaaprendizaje automáticoanálisis acústico

Más Videos Relacionados

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

Área de la Ciencia:

  • Neurología y Ciencia del Habla
  • Descubrimiento de Biomarcadores
  • Inteligencia Artificial en la Atención Médica

Sus antecedentes:

  • Los biomarcadores de voz muestran potencial para la detección temprana del Deterioro Cognitivo Leve (DCL).
  • Es esencial evaluar la eficacia de diferentes tareas de habla para el cribado del DCL.
  • La identificación de combinaciones de tareas óptimas puede mejorar la precisión diagnóstica.

Objetivo del estudio:

  • Evaluar el rendimiento de tareas de habla individuales y combinadas en la identificación del DCL.
  • Determinar qué combinaciones de tareas de habla producen la mayor precisión en la detección del DCL.
  • Investigar la contribución de las características acústicas frente a las lingüísticas en la clasificación del DCL.

Principales métodos:

  • Se diseñaron tres tareas de habla: Lectura Guionizada (Tarea 1), Preguntas y Respuestas Basadas en Imágenes (Tarea 2) y Narración de Habla Espontánea (Tarea 3).
  • Se analizaron 129 muestras de voz de 21 participantes.
  • Se utilizó la Eliminación Recursiva de Características con Validación Cruzada (RFECV) para identificar 32 características acústicas y lingüísticas clave de más de 1700.
  • Se evaluó un enfoque combinatorio de varias combinaciones de tareas para la modelización predictiva.

Principales resultados:

  • La combinación de las tres tareas (Tarea 1+2+3) logró el Área Bajo la Curva (AUC) más alta de 0.963.
  • La Tarea 3 (Narración de Habla Espontánea) fue integral para las combinaciones de alto rendimiento.
  • Las características acústicas, específicamente las derivadas de MFCC y los coeficientes de codificación lineal (LPC), fueron las más significativas para la clasificación.

Conclusiones:

  • La combinación de Lectura Guionizada, Preguntas y Respuestas Basadas en Imágenes y Narración de Habla Espontánea ofrece un rendimiento superior para el cribado del DCL.
  • Las tareas de habla espontánea son componentes críticos para modelos efectivos de detección del DCL.
  • Las características acústicas demuestran una mayor contribución a la precisión de la clasificación que las características lingüísticas.